187 related articles for article (PubMed ID: 15972123)
1. [Effects of berbamine on K562 cells and its mechanisms in vitro and in vivo].
Wu D; Lin MF; Zhao XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):373-8. PubMed ID: 15972123
[TBL] [Abstract][Full Text] [Related]
2. The antiproliferation effect of berbamine on k562 resistant cells by inhibiting NF-kappaB pathway.
Wei YL; Liang Y; Xu L; Zhao XY
Anat Rec (Hoboken); 2009 Jul; 292(7):945-50. PubMed ID: 19548306
[TBL] [Abstract][Full Text] [Related]
3. [The mechanism of apoptosis of chronic myeloid leukemia cells induced by the novel p210 bcr/abl inhibitor berbamine].
Sun JR; Zhang XH; He ZW; Gu Y; Yu YZ; Fang YM; Lü QH; Dong QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2246-51. PubMed ID: 17064567
[TBL] [Abstract][Full Text] [Related]
4. [Inhibitory effect of 4-chlorobenzoyl berbamine on imatinib-resistant K562 cells in vitro and in vivo].
Zhang YF; Xu GB; Gan YC; Xu XH; Xu RZ
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):1997-2001. PubMed ID: 22200699
[TBL] [Abstract][Full Text] [Related]
5. [Mechanism related to inhibition of leukemia K562 cells by berbamine].
WEI YL; XU L; ZHAO XY
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 38(4):387-91. PubMed ID: 19693977
[TBL] [Abstract][Full Text] [Related]
6. Berbamine: a novel inhibitor of bcr/abl fusion gene with potent anti-leukemia activity.
Xu R; Dong Q; Yu Y; Zhao X; Gan X; Wu D; Lu Q; Xu X; Yu XF
Leuk Res; 2006 Jan; 30(1):17-23. PubMed ID: 16023722
[TBL] [Abstract][Full Text] [Related]
7. Berbamine exhibits potent antitumor effects on imatinib-resistant CML cells in vitro and in vivo.
Wei YL; Xu L; Liang Y; Xu XH; Zhao XY
Acta Pharmacol Sin; 2009 Apr; 30(4):451-7. PubMed ID: 19270722
[TBL] [Abstract][Full Text] [Related]
8. [Effect of tetrandrine combined with Droloxifen on the expression of bcr/abl of K562 at both mRNA and protein levels].
Chen BA; Qian XJ; Cheng J; Gao F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):95-9. PubMed ID: 15748444
[TBL] [Abstract][Full Text] [Related]
9. [Apoptosis mechanism in human chronic myelogenous leukemia K562 cells induced by tetra-arsenic tetra-sulfide].
Ye QD; Gu LJ; Zhao YX; Zhao JC; Chen WG; Zhang B; Jiang LM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):759-63. PubMed ID: 16277837
[TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH
Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377
[TBL] [Abstract][Full Text] [Related]
11. [Effects of specific siRNA targeting at bcr-abl fusion gene and its combination with p27 gene clone on chronic myeloid leukemia cell line K562].
Wang W; DU Y; Lin GQ; Li NN; Sun BZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):606-11. PubMed ID: 20561411
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of p210(bcr/abl) by curcumin involves disrupting molecular chaperone functions of Hsp90.
Wu LX; Xu JH; Huang XW; Zhang KZ; Wen CX; Chen YZ
Acta Pharmacol Sin; 2006 Jun; 27(6):694-9. PubMed ID: 16723087
[TBL] [Abstract][Full Text] [Related]
13. BCR/ABL mRNA targeting small interfering RNA effects on proliferation and apoptosis in chronic myeloid leukemia.
Zhu XS; Lin ZY; Du J; Cao GX; Liu G
Asian Pac J Cancer Prev; 2014; 15(12):4773-80. PubMed ID: 24998540
[TBL] [Abstract][Full Text] [Related]
14. [Influence of Qingdai compound on expression of bcr/abl and JWA in K562 cells].
Dai HP; Shen Q; Zhou JW; Tang WY; Zhu GR; Xia W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):809-11. PubMed ID: 16277847
[TBL] [Abstract][Full Text] [Related]
15. [Mechanism of lithium chloride-induced proliferation inhibition and apoptosis of K562 leukemic cells].
Tang HR; He Q; Wang FC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):979-82. PubMed ID: 16403263
[TBL] [Abstract][Full Text] [Related]
16. [Effect of SU11248 on leukemia cell line K562 and its molecular mechanisms].
Luo LQ; Cheng X; Chen Y; Cui ZL; Lin DH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):965-70. PubMed ID: 25130811
[TBL] [Abstract][Full Text] [Related]
17. [Effect of emodin on proliferation inhibition and apoptosis induction in leukemic K562 cells].
Zheng ZH; Hu JD; Chen YY; Lian XL; Zheng HY; Zheng J; Lin MH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1434-8. PubMed ID: 20030921
[TBL] [Abstract][Full Text] [Related]
18. [Study on effect of berbamine on multidrug resistance leukemia K562/Adr cells].
Dong QH; Zheng S; Xu RZ; Lu Q; He L
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Sep; 24(9):820-2. PubMed ID: 15495829
[TBL] [Abstract][Full Text] [Related]
19. Curcumin synergistically augments bcr/abl phosphorothioate antisense oligonucleotides to inhibit growth of chronic myelogenous leukemia cells.
Zhang KZ; Xu JH; Huang XW; Wu LX; Su Y; Chen YZ
Acta Pharmacol Sin; 2007 Jan; 28(1):105-10. PubMed ID: 17184589
[TBL] [Abstract][Full Text] [Related]
20. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
